SCHEMBL20987744

SCHEMBL20987744

c1ccc(-c2ccc(Nc3cc(-c4ccccc4)cc4ccccc34)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ TP53 P04637 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ MMP2 P08253 5/20 0.44
▸ MMP9 P14780 5/20 0.44
▸ MMP13 P45452 5/20 0.44
▸ MMP8 P22894 3/20 0.44
▸ ABCB1 P08183 1/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.44
▸ ALK Q9UM73 1/20 0.43
▸ RAB9A P51151 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24553530 1.00 CDC25B (0.52) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL18201517 0.95 CDC25B (0.58) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL26021832 0.89 CDC25B (0.45) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL29104447 0.86 ALDH1A1 (0.47) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL30221995 0.86 ALDH1A1 (0.47) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL10136241 0.86 ALDH1A1 (0.47) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL29892417 0.86 ALDH1A1 (0.47) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL21203581 0.83 ALDH1A1 (0.58) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL25933165 0.83 ALDH1A1 (0.58) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL2794401 0.81 ALDH1A1 (0.78) CDC25BALDH1A1CYP3A4HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-11-02 — — US disclosed
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-11-02 — — US disclosed
EP-4258372-A1 ORGANIC LIGHT-EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-10-11 — — EP disclosed
WO-2023182836-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2023-09-28 — — WO disclosed
WO-2022131869-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2022-06-23 — — WO disclosed
WO-2022086297-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2022-04-28 — — WO disclosed
US-20210376241-A1 AMINE-SUBSTITUTED NAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES INCLUDING THE SAME SFC CO., LTD. (KR) 2021-12-02 — — US disclosed
US-20190140177-A1 AMINE-SUBSTITUTED NAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES INCLUDING THE SAME SFC CO., LTD. (KR) 2019-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376241-A1 AMINE-SUBSTITUTED NAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES INCLUDING THE SAME ARNT, SUN2, SLC7A5 CDC25B 2621/4885ALDH1A1 570/4885CYP3A4 801/4885
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, PER2 CDC25B 627/4885ALDH1A1 48/4885CYP3A4 137/4885
US-20190140177-A1 AMINE-SUBSTITUTED NAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES INCLUDING THE SAME ARNT, SUN2, SLC7A5 CDC25B 2621/4885ALDH1A1 570/4885CYP3A4 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback